The global Class Ⅱ AI Medical Imaging Software market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

Class II AI Medical Imaging Software is a moderate-risk medical device software that leverages artificial intelligence to assist physicians in diagnosing and analyzing medical images. This type of software is typically used to identify abnormalities, assess disease progression, or support surgical planning, enhancing the accuracy and efficiency of diagnostics while still requiring final interpretation by healthcare professionals.

From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Class Ⅱ AI Medical Imaging Software leading manufacturers including Yizhun Intelligent, Deepwise, Fosun Aitrox, Shukun Technology, Infervision Medical, Airdoc, Diagens Biotechnology, etc., dominate supply; the top five capture approximately % of global revenue, with Yizhun Intelligent leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Class Ⅱ AI Medical Imaging Software market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Class Ⅱ AI Medical Imaging Software Market Report

Report Metric	Details
Report Name	Class Ⅱ AI Medical Imaging Software Market
Segment by Type	Cardiovascular Pulmonary Cerebral Others
Segment by Application	Hospital Clinic
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Yizhun Intelligent, Deepwise, Fosun Aitrox, Shukun Technology, Infervision Medical, Airdoc, Diagens Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Class Ⅱ AI Medical Imaging Software study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Class Ⅱ AI Medical Imaging Software Market report?

Ans: The main players in the Class Ⅱ AI Medical Imaging Software Market are Yizhun Intelligent, Deepwise, Fosun Aitrox, Shukun Technology, Infervision Medical, Airdoc, Diagens Biotechnology

What are the Application segmentation covered in the Class Ⅱ AI Medical Imaging Software Market report?

Ans: The Applications covered in the Class Ⅱ AI Medical Imaging Software Market report are Hospital, Clinic

What are the Type segmentation covered in the Class Ⅱ AI Medical Imaging Software Market report?

Ans: The Types covered in the Class Ⅱ AI Medical Imaging Software Market report are Cardiovascular, Pulmonary, Cerebral, Others

1 Study Coverage

1.1 Introduction to Class Ⅱ AI Medical Imaging Software: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Class Ⅱ AI Medical Imaging Software Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Cardiovascular

1.2.3 Pulmonary

1.2.4 Cerebral

1.2.5 Others

1.3 Market Segmentation by Application

1.3.1 Global Class Ⅱ AI Medical Imaging Software Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Class Ⅱ AI Medical Imaging Software Revenue Estimates and Forecasts 2020-2031

2.2 Global Class Ⅱ AI Medical Imaging Software Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global Class Ⅱ AI Medical Imaging Software Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Class Ⅱ AI Medical Imaging Software Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Cardiovascular Market Size by Players

3.3.2 Pulmonary Market Size by Players

3.3.3 Cerebral Market Size by Players

3.3.4 Others Market Size by Players

3.4 Global Class Ⅱ AI Medical Imaging Software Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Class Ⅱ AI Medical Imaging Software Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Class Ⅱ AI Medical Imaging Software Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Class Ⅱ AI Medical Imaging Software Market Size by Type (2020-2031)

6.4 North America Class Ⅱ AI Medical Imaging Software Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Class Ⅱ AI Medical Imaging Software Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Class Ⅱ AI Medical Imaging Software Market Size by Type (2020-2031)

7.4 Europe Class Ⅱ AI Medical Imaging Software Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Class Ⅱ AI Medical Imaging Software Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Class Ⅱ AI Medical Imaging Software Market Size by Type (2020-2031)

8.4 Asia-Pacific Class Ⅱ AI Medical Imaging Software Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Class Ⅱ AI Medical Imaging Software Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Class Ⅱ AI Medical Imaging Software Market Size by Type (2020-2031)

9.4 Central and South America Class Ⅱ AI Medical Imaging Software Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Class Ⅱ AI Medical Imaging Software Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Class Ⅱ AI Medical Imaging Software Market Size by Type (2020-2031)

10.4 Middle East and Africa Class Ⅱ AI Medical Imaging Software Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Class Ⅱ AI Medical Imaging Software Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Yizhun Intelligent

11.1.1 Yizhun Intelligent Corporation Information

11.1.2 Yizhun Intelligent Business Overview

11.1.3 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Product Features and Attributes

11.1.4 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)

11.1.5 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Revenue by Product in 2024

11.1.6 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Revenue by Application in 2024

11.1.7 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software Revenue by Geographic Area in 2024

11.1.8 Yizhun Intelligent Class Ⅱ AI Medical Imaging Software SWOT Analysis

11.1.9 Yizhun Intelligent Recent Developments

11.2 Deepwise

11.2.1 Deepwise Corporation Information

11.2.2 Deepwise Business Overview

11.2.3 Deepwise Class Ⅱ AI Medical Imaging Software Product Features and Attributes

11.2.4 Deepwise Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)

11.2.5 Deepwise Class Ⅱ AI Medical Imaging Software Revenue by Product in 2024

11.2.6 Deepwise Class Ⅱ AI Medical Imaging Software Revenue by Application in 2024

11.2.7 Deepwise Class Ⅱ AI Medical Imaging Software Revenue by Geographic Area in 2024

11.2.8 Deepwise Class Ⅱ AI Medical Imaging Software SWOT Analysis

11.2.9 Deepwise Recent Developments

11.3 Fosun Aitrox

11.3.1 Fosun Aitrox Corporation Information

11.3.2 Fosun Aitrox Business Overview

11.3.3 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Product Features and Attributes

11.3.4 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)

11.3.5 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Revenue by Product in 2024

11.3.6 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Revenue by Application in 2024

11.3.7 Fosun Aitrox Class Ⅱ AI Medical Imaging Software Revenue by Geographic Area in 2024

11.3.8 Fosun Aitrox Class Ⅱ AI Medical Imaging Software SWOT Analysis

11.3.9 Fosun Aitrox Recent Developments

11.4 Shukun Technology

11.4.1 Shukun Technology Corporation Information

11.4.2 Shukun Technology Business Overview

11.4.3 Shukun Technology Class Ⅱ AI Medical Imaging Software Product Features and Attributes

11.4.4 Shukun Technology Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)

11.4.5 Shukun Technology Class Ⅱ AI Medical Imaging Software Revenue by Product in 2024

11.4.6 Shukun Technology Class Ⅱ AI Medical Imaging Software Revenue by Application in 2024

11.4.7 Shukun Technology Class Ⅱ AI Medical Imaging Software Revenue by Geographic Area in 2024

11.4.8 Shukun Technology Class Ⅱ AI Medical Imaging Software SWOT Analysis

11.4.9 Shukun Technology Recent Developments

11.5 Infervision Medical

11.5.1 Infervision Medical Corporation Information

11.5.2 Infervision Medical Business Overview

11.5.3 Infervision Medical Class Ⅱ AI Medical Imaging Software Product Features and Attributes

11.5.4 Infervision Medical Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)

11.5.5 Infervision Medical Class Ⅱ AI Medical Imaging Software Revenue by Product in 2024

11.5.6 Infervision Medical Class Ⅱ AI Medical Imaging Software Revenue by Application in 2024

11.5.7 Infervision Medical Class Ⅱ AI Medical Imaging Software Revenue by Geographic Area in 2024

11.5.8 Infervision Medical Class Ⅱ AI Medical Imaging Software SWOT Analysis

11.5.9 Infervision Medical Recent Developments

11.6 Airdoc

11.6.1 Airdoc Corporation Information

11.6.2 Airdoc Business Overview

11.6.3 Airdoc Class Ⅱ AI Medical Imaging Software Product Features and Attributes

11.6.4 Airdoc Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)

11.6.5 Airdoc Recent Developments

11.7 Diagens Biotechnology

11.7.1 Diagens Biotechnology Corporation Information

11.7.2 Diagens Biotechnology Business Overview

11.7.3 Diagens Biotechnology Class Ⅱ AI Medical Imaging Software Product Features and Attributes

11.7.4 Diagens Biotechnology Class Ⅱ AI Medical Imaging Software Revenue and Gross Margin (2020-2025)

11.7.5 Diagens Biotechnology Recent Developments

12 Class Ⅱ AI Medical Imaging SoftwareIndustry Chain Analysis

12.1 Class Ⅱ AI Medical Imaging Software Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Class Ⅱ AI Medical Imaging Software Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Class Ⅱ AI Medical Imaging Software Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Diagens Biotechnology

List of Tables

Table 1. Global Class Ⅱ AI Medical Imaging Software Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Class Ⅱ AI Medical Imaging Software Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Class Ⅱ AI Medical Imaging Software Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Class Ⅱ AI Medical Imaging Software Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global Class Ⅱ AI Medical Imaging Software Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global Class Ⅱ AI Medical Imaging Software Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global Class Ⅱ AI Medical Imaging Software by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Class Ⅱ AI Medical Imaging Software as of 2024)

Table 11. Global Class Ⅱ AI Medical Imaging Software Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global Class Ⅱ AI Medical Imaging Software Companies Headquarters

Table 13. Global Class Ⅱ AI Medical Imaging Software Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global Class Ⅱ AI Medical Imaging Software Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global Class Ⅱ AI Medical Imaging Software Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global Class Ⅱ AI Medical Imaging Software Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global Class Ⅱ AI Medical Imaging Software Revenue by Application (2026-2031) & (US$ Million)

Table 21. Class Ⅱ AI Medical Imaging Software High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America Class Ⅱ AI Medical Imaging Software Growth Accelerators and Market Barriers

Table 25. North America Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe Class Ⅱ AI Medical Imaging Software Growth Accelerators and Market Barriers

Table 27. Europe Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific Class Ⅱ AI Medical Imaging Software Growth Accelerators and Market Barriers

Table 29. Asia-Pacific Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America Class Ⅱ AI Medical Imaging Software Investment Opportunities and Key Challenges

Table 31. Central and South America Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa Class Ⅱ AI Medical Imaging Software Investment Opportunities and Key Challenges

Table 33. Middle East and Africa Class Ⅱ AI Medical Imaging Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. Yizhun Intelligent Corporation Information

Table 35. Yizhun Intelligent Description and Major Businesses

Table 36. Yizhun Intelligent Product Features and Attributes

Table 37. Yizhun Intelligent Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. Yizhun Intelligent Revenue Proportion by Product in 2024

Table 39. Yizhun Intelligent Revenue Proportion by Application in 2024

Table 40. Yizhun Intelligent Revenue Proportion by Geographic Area in 2024

Table 41. Yizhun Intelligent Class Ⅱ AI Medical Imaging Software SWOT Analysis

Table 42. Yizhun Intelligent Recent Developments

Table 43. Deepwise Corporation Information

Table 44. Deepwise Description and Major Businesses

Table 45. Deepwise Product Features and Attributes

Table 46. Deepwise Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Deepwise Revenue Proportion by Product in 2024

Table 48. Deepwise Revenue Proportion by Application in 2024

Table 49. Deepwise Revenue Proportion by Geographic Area in 2024

Table 50. Deepwise Class Ⅱ AI Medical Imaging Software SWOT Analysis

Table 51. Deepwise Recent Developments

Table 52. Fosun Aitrox Corporation Information

Table 53. Fosun Aitrox Description and Major Businesses

Table 54. Fosun Aitrox Product Features and Attributes

Table 55. Fosun Aitrox Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. Fosun Aitrox Revenue Proportion by Product in 2024

Table 57. Fosun Aitrox Revenue Proportion by Application in 2024

Table 58. Fosun Aitrox Revenue Proportion by Geographic Area in 2024

Table 59. Fosun Aitrox Class Ⅱ AI Medical Imaging Software SWOT Analysis

Table 60. Fosun Aitrox Recent Developments

Table 61. Shukun Technology Corporation Information

Table 62. Shukun Technology Description and Major Businesses

Table 63. Shukun Technology Product Features and Attributes

Table 64. Shukun Technology Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. Shukun Technology Revenue Proportion by Product in 2024

Table 66. Shukun Technology Revenue Proportion by Application in 2024

Table 67. Shukun Technology Revenue Proportion by Geographic Area in 2024

Table 68. Shukun Technology Class Ⅱ AI Medical Imaging Software SWOT Analysis

Table 69. Shukun Technology Recent Developments

Table 70. Infervision Medical Corporation Information

Table 71. Infervision Medical Description and Major Businesses

Table 72. Infervision Medical Product Features and Attributes

Table 73. Infervision Medical Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. Infervision Medical Revenue Proportion by Product in 2024

Table 75. Infervision Medical Revenue Proportion by Application in 2024

Table 76. Infervision Medical Revenue Proportion by Geographic Area in 2024

Table 77. Infervision Medical Class Ⅱ AI Medical Imaging Software SWOT Analysis

Table 78. Infervision Medical Recent Developments

Table 79. Airdoc Corporation Information

Table 80. Airdoc Description and Major Businesses

Table 81. Airdoc Product Features and Attributes

Table 82. Airdoc Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. Airdoc Recent Developments

Table 84. Diagens Biotechnology Corporation Information

Table 85. Diagens Biotechnology Description and Major Businesses

Table 86. Diagens Biotechnology Product Features and Attributes

Table 87. Diagens Biotechnology Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. Diagens Biotechnology Recent Developments

Table 89. Raw Materials Key Suppliers

Table 90. Distributors List

Table 91. Market Trends and Market Evolution

Table 92. Market Drivers and Opportunities

Table 93. Market Challenges, Risks, and Restraints

Table 94. Research Programs/Design for This Report

Table 95. Key Data Information from Secondary Sources

Table 96. Key Data Information from Primary Sources

List of Figures

Figure 1. Class Ⅱ AI Medical Imaging Software Product Picture

Figure 2. Global Class Ⅱ AI Medical Imaging Software Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Cardiovascular Product Picture

Figure 4. Pulmonary Product Picture

Figure 5. Cerebral Product Picture

Figure 6. Others Product Picture

Figure 7. Global Class Ⅱ AI Medical Imaging Software Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Class Ⅱ AI Medical Imaging Software Report Years Considered

Figure 11. Global Class Ⅱ AI Medical Imaging Software Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 13. Global Class Ⅱ AI Medical Imaging Software Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 14. Global Class Ⅱ AI Medical Imaging Software Revenue Market Share by Region (2020-2031)

Figure 15. Global Class Ⅱ AI Medical Imaging Software Revenue Market Share Ranking (2024)

Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 17. Cardiovascular Revenue Market Share by Player in 2024

Figure 18. Pulmonary Revenue Market Share by Player in 2024

Figure 19. Cerebral Revenue Market Share by Player in 2024

Figure 20. Others Revenue Market Share by Player in 2024

Figure 21. Global Class Ⅱ AI Medical Imaging Software Revenue Market Share by Type (2020-2031)

Figure 22. Global Class Ⅱ AI Medical Imaging Software Revenue Market Share by Application (2020-2031)

Figure 23. North America Class Ⅱ AI Medical Imaging Software Revenue YoY (2020-2031) & (US$ Million)

Figure 24. North America Top 5 Players Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) in 2024

Figure 25. North America Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Type (2020 - 2031)

Figure 26. North America Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Application (2020-2031)

Figure 27. US Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 28. Canada Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 29. Mexico Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 30. Europe Class Ⅱ AI Medical Imaging Software Revenue YoY (2020-2031) & (US$ Million)

Figure 31. Europe Top 5 Players Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) in 2024

Figure 32. Europe Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Type (2020-2031)

Figure 33. Europe Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Application (2020-2031)

Figure 34. Germany Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 35. France Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 36. U.K. Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 37. Italy Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 38. Russia Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 39. Asia-Pacific Class Ⅱ AI Medical Imaging Software Revenue YoY (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Top 8 Players Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) in 2024

Figure 41. Asia-Pacific Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Type (2020-2031)

Figure 42. Asia-Pacific Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Application (2020-2031)

Figure 43. Indonesia Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 44. Japan Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 45. South Korea Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 46. Australia Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 47. India Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 48. Indonesia Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 49. Vietnam Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 50. Malaysia Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 51. Philippines Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 52. Singapore Class Ⅱ AI Medical Imaging Software Revenue (2020-2031) & (US$ Million)

Figure 53. Central and South America Class Ⅱ AI Medical Imaging Software Revenue YoY (2020-2031) & (US$ Million)

Figure 54. Central and South America Top 5 Players Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) in 2024

Figure 55. Central and South America Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Type (2020-2031)

Figure 56. Central and South America Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Application (2020-2031)

Figure 57. Brazil Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)

Figure 58. Argentina Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)

Figure 59. Middle East and Africa Class Ⅱ AI Medical Imaging Software Revenue YoY (2020-2031) & (US$ Million)

Figure 60. Middle East and Africa Top 5 Players Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) in 2024

Figure 61. South America Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Type (2020-2031)

Figure 62. Middle East and Africa Class Ⅱ AI Medical Imaging Software Revenue (US$ Million) by Application (2020-2031)

Figure 63. GCC Countries Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)

Figure 64. Israel Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)

Figure 65. Egypt Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)

Figure 66. South Africa Class Ⅱ AI Medical Imaging Software Revenue (2020-2025) & (US$ Million)

Figure 67. Class Ⅱ AI Medical Imaging Software Industry Chain Mapping

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Spinal Needle for Surgery Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37D12504

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Kidney Disease Management Software Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30D17962

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Renal Care Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39G18133

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global AI-powered Care Coordination Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4N20277

Fri Nov 28 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions